Binding of aromatic isonitriles to haemoglobin and myoglobin

A series of aromatic isonitriles were synthesized and their binding to sheep haemoglobin and horse heart myoglobin was investigated. The disubstituted ligands 2,6-dimethylphenylisonitrile and 2,6-diethylphenylisonitrile were found to bind to horse-heart myoglobin with affinities ranging from 500 to 5000 times greater than that of ethylisonitrile (4.6 x 10(-6) M) which has been the tightest binding isonitrile ligand for myoglobin thus far reported. The tight binding was not found to vary significantly with pH or temperature. An explanation for the unexpectedly high affinity is offered in terms of the electronic structure of aromatic isonitriles.

The effect of concanavalin A on the rat electro-olfactogram at various odorant concentrations

We have studied the effect of concanavalin A (Con A) on the rat electro-olfactogram response to several odorants. Each odorant was applied over a range of concentrations. For hydrophobic odorants whose response was affected by Con A, the diminution in response was maximal at odorant concentrations of about 1 microM in the olfactory mucus. The (odour) concentration-dependence of the change is compatible with the idea that Con A inactivates one or more types of olfactory receptor that normally bind odorants with dissociation constants of the order of 100 nM. With hydrophilic odorants we had to apply concentrations very much higher than this to elicit any response from the system. At these high concentrations we could observe Con A-induced diminutions in response.

Renal function in the fetal lamb: a chronic model to study physiological effects of ureteral ligation and deligation

Between 53 and 98 days of gestation 11 fetal lambs were subjected to unilateral ureteral ligation. In 8 fetuses re-exploration was performed 35 to 41 days after ligation. Chronic catheterization of the obstructed kidney, bladder and fetal vascular system was used for analysis of physiological data. Average creatinine clearance was 1.35 +/- 0.067 ml. per minute in the control kidney and 0.226 +/- 0.057 ml. per minute in the obstructed kidney after diversion. Free water clearance, osmolar clearance and fractional sodium excretions were not statistically significantly different in control and obstructed kidneys.

Oliguria and tolazoline pharmacokinetics in the newborn

Tolazoline treatment of neonates has been reported since 1965. Dosages increased from pulse doses of 1 to 2 mg/kg to continuous infusions of 10 mg/kg X h before neonatal plasma tolazoline concentrations were measured. We developed a microassay for tolazoline and determined neonatal distribution volume, 1.61 +/- 0.21 L/kg, and disposition rate constant (beta), 0.0027 +/- 0.005 min-1 (mean +/- SEM). Half-life (gamma) ranged from 1.47 to 41.25 (median = 4.43) hours and correlated inversely with urine output (x); y (h) = -0.46 + 7.63/x (mL/kg X h), r = .61, P less than .05. The highest plasma tolazoline concentration in a neonate was 20.3 mg/L. Lethal tolazoline concentrations in lambs ranged from 21.8 to 56.8 mg/L. Initial tolazoline concentrations during infusions and after 1- to 2-mg/kg pulse doses ranged from 0.35 to 2.3 mg/L and PaO2 increased greater than or equal to 15 mm Hg in 64% of 14 treatments. The average neonatal pharmacokinetics predict that each 1 mg of tolazoline HCl per kilogram pulse dose will increase the plasma concentration of tolazoline base by 0.5 mg/L. The plasma concentration should remain constant with infusion dose increments of 0.16 mg of tolazoline HCl per kilogram per hour for every 1.0-mg/kg loading dose. Tolazoline dose requirements for specific patients will vary, especially with renal dysfunction. Reduced tolazoline doses were used to treat two patients, concentrations remained constant, and PaO2 was maintained. Tolazoline doses derived from neonatal kinetics are less than current infusion doses and may avoid high concentrations.

Effect of diltiazem and ibuprofen on right ventricular hypertrophy in an experimental model of hypoxic pulmonary hypertension

The effectiveness of diltiazem, a slow channel calcium blocker, ibuprofen, a nonselective inhibitor of prostanoid synthesis, and the selective inhibition of thromboxane A2 with imidazole and UK-38,485 in retarding the development of right ventricular (RV) hypertrophy was assessed in a rat model of chronic hypoxic pulmonary hypertension. Both ibuprofen and diltiazem significantly reduced RV hypertrophy in the chronically hypoxic rat. In contrast, selective inhibition of thromboxane A2 was ineffective in reducing RV hypertrophy. The beneficial effect of ibuprofen was unrelated to inhibition of thromboxane A2. Furthermore, thromboxane A2 did not appear to be involved in the development of RV hypertrophy in this experimental model of hypoxic pulmonary hypertension.

Coronary artery spasm after abrupt withdrawal of nitroglycerin in rabbits

The potential for abrupt withdrawal of nitroglycerin (NTG) to create coronary artery spasm was assessed in New Zealand white rabbits. In the control setting, electrocardiograms were taken from 7 anesthetized rabbits. The administration of intravenous ergonovine did not provoke ST-segment shifts or arrhythmias. Two inches of topical NTG (2%) was applied 3 times daily to a shaved area on the back of each rabbit over a 6-week period. Forty hours after abrupt withdrawal of NTG, intravenous ergonovine and indomethacin were given. Six of 7 rabbits had electrocardiographic changes: ventricular tachycardia in 2, ventricular fibrillation in 1, and significant (1 mm or more) ST-segment shifts in 5 rabbits. Three rabbits died. Sixty-four hours after NTG administration the remaining 4 rabbits were reexamined. One had baseline electrocardiographic evidence of severe myocardial ischemia. Repeat ergonovine and indomethacin testing in the others revealed ventricular tachycardia progressing to asystole in 1, premature ventricular complexes in 1, and ST-segment elevation in another. Two of the remaining 4 rabbits died. Eighty-two hours after NTG administration the remaining 2 rabbits were found dead in their cages. Nitroblue tetrazolium studies revealed extensive myocardial infarction in both animals. Additional studies were performed in 10 normal rabbits. Neither ergonovine nor indomethacin induced ST-segment shifts or arrhythmias in this control population.(ABSTRACT TRUNCATED AT 250 WORDS)

The release of thromboxane A2 and prostacyclin following experimental acute pulmonary embolism

The contributions of thromboxane A2 (TXA2) and prostacyclin (PGI2) to the effects of acute pulmonary embolism were evaluated in 18 open-chest rabbits. All rabbits received autologous whole-blood-clot embolus (.4 cc) by way of a catheter in the right ventricle. Pulmonary artery (PA) and left atrial (LA) pressures, and aortic flow (AOQ) were recorded. The stable metabolites of TXA2 (TXB2) and PGI2 (6-Keto PGF1) were assayed by radioimmunoassay at pre- and post-embolization periods (+5, +10, +20, +30, and +40 minutes). Significant elevations of pulmonary vascular resistance (PVR) (normalized), PA pressure, and reduction of AOQ were noted comparing pre-embolus to +5 minute time intervals. A negative correlation was reached between PGI2 and AOQ at +40 minutes (p less than .05). Five of the 13 rabbits died prematurely. At +5 minutes these 5 rabbits had higher PVR (p less than .001) and lower AOQ (p less than .01) than their living counterparts. At +10 minutes AOQ was still significantly lower (p less than .005) and TXB2 was higher (p less than .05) in the premature death group. We conclude that TXB2 is significantly but transiently elevated early following acute pulmonary embolism and may contribute to mortality. In contrast PGI2 does not appear to play an immediate role in the hemodynamic events following embolization but does rise to significant levels later in the course possibly in an attempt to compensate for reduced flow.

Myocardial hydroxyproline reduced by early administration of methylprednisolone or ibuprofen to rabbits with radiation-induced heart disease

The ability of methylprednisolone (MP) and ibuprofen (IB) to reduce the severity of the late state of radiation-induced heart disease was assessed in 57 New Zealand white rabbits. Before and shortly after cardiac irradiation, 15 rabbits received i.v. MP, 30 mg/kg twice daily for 3 days, and 15 others received IB, 12.5 mg/kg twice daily for 2 days. No drug was administered to 14 irradiated rabbits, and neither irradiation nor drugs were administered to 13 rabbits that served as controls, All 15 rabbits treated with MP and 13 of the 15 treated with IB lived for 100 days. Only seven of the untreated, irradiated rabbits lived that long. Longevity of each treated group of rabbits was better (p less than 0.01 and 0.05) than that of the untreated, irradiated rabbits. Surviving rabbits were killed 100 days after irradiation. Pericarditis (p less than 0.05) and pericardial effusion (p less than 0.01) were less frequent in the treated, irradiated groups than in the untreated, irradiated rabbits. At least some rabbits in each irradiated group had microscopic evidence of myocardial fibrosis. The fibrosis was quantitated by determination of myocardial hydroxyproline concentrations (MHP). MHP concentration in the untreated, irradiated rabbits was greater than in those treated with MP (p less than 0.05) or IB (p less than 0.01) and in the untreated, unirradiated rabbits (p less than 0.01). Early administration of MP or IB retarded the development of myocardial fibrosis, pericarditis and pericardial effusion, and improved survival in this experimental model of radiation-induced heart disease.

A high-pressure liquid chromatographic method for the determination of N-acetyl-p-aminophenol (acetaminophen) in serum or plasma using a direct injection technique

N-Acetyl-p-aminophenol (acetaminophen) is becoming more prevalent as an intoxicant in accidental or intentional overdose, therefore, a direct injection ultra-micro high-pressure liquid chromatographic (HPLC) method has been developed for its quantitation. The HPLC analysis was performed using a Model 110 Solvent Metering Pump equipped with a Model 110-19 Pressure Filter (Altex Scientific, Berkeley, CA), a Model 7120 Rheodyne Injector (Rheodyne, Berkeley, CA) or a Model U6K Injector (Waters Associates, Milford, MA) a Model 440 Absorbance Detector (Water's Associates), and a Model 3380A Recorder Integrator (Hewlett Packard, Avondale, PA). A commercially prepared muBonapak C18 Column (Water's Associates) was used. Acetaminophen was eluted with a mixture of 0.01 mol/L aqueous sodium acetate, pH 4.0: acetonitrile (93:7) and the absorbance detector was operated wih a 254 nm filter. The method, which requires only 2 microL of serum or plasma for analysis, offers several distinct advantages to the analyst. No pre- or post-column extraction or other manipulation of the specimen is required to obtain a quantitative result. Rapid processing of the specimen is possible because both acetaminophen and the internal standard are eluted in less than 10 minutes. The small sample (2 microL) is ideal for use with pediatric patients.